Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil

Objectives. MMF is cleaved in the acidic milieu of the gastric compartment. However, its absorption might be impeded by proton pump inhibitors (PPIs), which suppress acid production and thus increase stomach pH. Since PPIs are widely used, it is useful to clarify whether the total drug amount of MMF...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schaier, Matthias (VerfasserIn) , Scholl, Markus (VerfasserIn) , Scharpf, Dominik (VerfasserIn) , Hug, Friederike (VerfasserIn) , Bönisch-Schmidt, Sabine (VerfasserIn) , Dikow, Ralf (VerfasserIn) , Schmitt, Wilhelm (VerfasserIn) , Schwenger, Vedat (VerfasserIn) , Zeier, Martin (VerfasserIn) , Sommerer, Claudia (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 July 2010
In: Rheumatology
Year: 2010, Jahrgang: 49, Heft: 11, Pages: 2061-2067
ISSN:1462-0332
DOI:10.1093/rheumatology/keq238
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/rheumatology/keq238
Volltext
Verfasserangaben:Matthias Schaier, Christian Scholl, Dominik Scharpf, Friederike Hug, Sabine Bönisch-Schmidt, Ralf Dikow, Wilhelm H. Schmitt, Vedat Schwenger, Martin Zeier and Claudia Sommerer

MARC

LEADER 00000caa a2200000 c 4500
001 1855136945
003 DE-627
005 20240311125941.0
007 cr uuu---uuuuu
008 230810s2010 xx |||||o 00| ||eng c
024 7 |a 10.1093/rheumatology/keq238  |2 doi 
035 |a (DE-627)1855136945 
035 |a (DE-599)KXP1855136945 
035 |a (OCoLC)1425874349 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schaier, Matthias  |d 1975-  |e VerfasserIn  |0 (DE-588)129029009  |0 (DE-627)387780335  |0 (DE-576)297455788  |4 aut 
245 1 0 |a Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil  |c Matthias Schaier, Christian Scholl, Dominik Scharpf, Friederike Hug, Sabine Bönisch-Schmidt, Ralf Dikow, Wilhelm H. Schmitt, Vedat Schwenger, Martin Zeier and Claudia Sommerer 
264 1 |c 29 July 2010 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am10.08.2023 
520 |a Objectives. MMF is cleaved in the acidic milieu of the gastric compartment. However, its absorption might be impeded by proton pump inhibitors (PPIs), which suppress acid production and thus increase stomach pH. Since PPIs are widely used, it is useful to clarify whether the total drug amount of MMF is available in patients undergoing PPI treatment.Methods. We analysed 36 patients with autoimmune diseases under stable MMF maintenance therapy. Twenty-three patients received co-medication with pantoprazole; 13 patients received no treatment with PPIs or antacids. To assess the immunosuppressive potency, we measured mycophenolic acid levels and inosin monophosphate dehydrogenase (IMPDH) activity with a validated HPLC method in plasma samples collected pre-dose and at 0.5, 1, 1.5, 2, 3, 4, 5, 6, 8, 10 and 12 h after oral administration.Results. The mean MMF dosage of the non-PPI patients was 770 (249) mg/12 h and 771 (291) mg/12 h in pantoprazole-treated patients (NS). The total area under the curve of MMF showed a 37% reduction in PPI patients vs those treated with no PPIs (P < 0.01), and the maximum peak concentration of MMF was 60% lower in the pantoprazole patients (P < 0.001). The MMF exposure correlated with the inhibition of IMPDH activity. The area of enzyme activity curve was 42% higher in the PPI patients (P < 0.01).Conclusions. The co-medication of pantoprazole with MMF significantly influences the drug exposure and immunosuppressive potency of MMF in patients with autoimmune diseases. This finding might at least partly explain the different outcomes in studies using MMF for maintenance therapy. 
700 1 |a Scholl, Markus  |d 1982-  |e VerfasserIn  |0 (DE-588)143523821  |0 (DE-627)647311631  |0 (DE-576)337516138  |4 aut 
700 1 |a Scharpf, Dominik  |d 1982-  |e VerfasserIn  |0 (DE-588)14300560X  |0 (DE-627)641428847  |0 (DE-576)334572274  |4 aut 
700 1 |a Hug, Friederike  |e VerfasserIn  |0 (DE-588)1145068014  |0 (DE-627)1005287600  |0 (DE-576)495605328  |4 aut 
700 1 |a Bönisch-Schmidt, Sabine  |e VerfasserIn  |4 aut 
700 1 |a Dikow, Ralf  |d 1973-  |e VerfasserIn  |0 (DE-588)12216217X  |0 (DE-627)705795497  |0 (DE-576)293125899  |4 aut 
700 1 |a Schmitt, Wilhelm  |d 1960-  |e VerfasserIn  |0 (DE-588)1048670813  |0 (DE-627)780888235  |0 (DE-576)402969502  |4 aut 
700 1 |a Schwenger, Vedat  |e VerfasserIn  |0 (DE-588)1022867652  |0 (DE-627)717320197  |0 (DE-576)176592237  |4 aut 
700 1 |a Zeier, Martin  |e VerfasserIn  |0 (DE-588)1026480302  |0 (DE-627)726772356  |0 (DE-576)371826438  |4 aut 
700 1 |a Sommerer, Claudia  |d 1971-  |e VerfasserIn  |0 (DE-588)121857654  |0 (DE-627)705680002  |0 (DE-576)292921829  |4 aut 
773 0 8 |i Enthalten in  |t Rheumatology  |d Oxford : Oxford Univ. Press, 1999  |g 49(2010), 11, Seite 2061-2067  |h Online-Ressource  |w (DE-627)269242813  |w (DE-600)1474143-X  |w (DE-576)077883799  |x 1462-0332  |7 nnas  |a Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil 
773 1 8 |g volume:49  |g year:2010  |g number:11  |g pages:2061-2067  |g extent:7  |a Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil 
856 4 0 |u https://doi.org/10.1093/rheumatology/keq238  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230810 
993 |a Article 
994 |a 2010 
998 |g 121857654  |a Sommerer, Claudia  |m 121857654:Sommerer, Claudia  |d 50000  |e 50000PS121857654  |k 0/50000/  |p 10  |y j 
998 |g 1026480302  |a Zeier, Martin  |m 1026480302:Zeier, Martin  |d 910000  |d 910100  |d 50000  |e 910000PZ1026480302  |e 910100PZ1026480302  |e 50000PZ1026480302  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 9 
998 |g 1022867652  |a Schwenger, Vedat  |m 1022867652:Schwenger, Vedat  |d 50000  |e 50000PS1022867652  |k 0/50000/  |p 8 
998 |g 1048670813  |a Schmitt, Wilhelm  |m 1048670813:Schmitt, Wilhelm  |d 60000  |e 60000PS1048670813  |k 0/60000/  |p 7 
998 |g 12216217X  |a Dikow, Ralf  |m 12216217X:Dikow, Ralf  |d 50000  |e 50000PD12216217X  |k 0/50000/  |p 6 
998 |g 1145068014  |a Hug, Friederike  |m 1145068014:Hug, Friederike  |d 910000  |d 911600  |e 910000PH1145068014  |e 911600PH1145068014  |k 0/910000/  |k 1/910000/911600/  |p 4 
998 |g 14300560X  |a Scharpf, Dominik  |m 14300560X:Scharpf, Dominik  |d 50000  |e 50000PS14300560X  |k 0/50000/  |p 3 
998 |g 143523821  |a Scholl, Christian  |m 143523821:Scholl, Christian  |d 50000  |e 50000PS143523821  |k 0/50000/  |p 2 
998 |g 129029009  |a Schaier, Matthias  |m 129029009:Schaier, Matthias  |d 50000  |e 50000PS129029009  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1855136945  |e 436471321X 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Matthias","family":"Schaier","role":"aut","display":"Schaier, Matthias"},{"given":"Markus","display":"Scholl, Markus","family":"Scholl","role":"aut"},{"given":"Dominik","family":"Scharpf","role":"aut","display":"Scharpf, Dominik"},{"display":"Hug, Friederike","role":"aut","family":"Hug","given":"Friederike"},{"given":"Sabine","role":"aut","family":"Bönisch-Schmidt","display":"Bönisch-Schmidt, Sabine"},{"display":"Dikow, Ralf","family":"Dikow","role":"aut","given":"Ralf"},{"display":"Schmitt, Wilhelm","family":"Schmitt","role":"aut","given":"Wilhelm"},{"given":"Vedat","role":"aut","family":"Schwenger","display":"Schwenger, Vedat"},{"display":"Zeier, Martin","role":"aut","family":"Zeier","given":"Martin"},{"given":"Claudia","family":"Sommerer","role":"aut","display":"Sommerer, Claudia"}],"note":["Gesehen am10.08.2023"],"language":["eng"],"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"29 July 2010"}],"name":{"displayForm":["Matthias Schaier, Christian Scholl, Dominik Scharpf, Friederike Hug, Sabine Bönisch-Schmidt, Ralf Dikow, Wilhelm H. Schmitt, Vedat Schwenger, Martin Zeier and Claudia Sommerer"]},"recId":"1855136945","id":{"eki":["1855136945"],"doi":["10.1093/rheumatology/keq238"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"7 S."}],"title":[{"title_sort":"Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil","title":"Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil"}],"relHost":[{"title":[{"title_sort":"Rheumatology","title":"Rheumatology"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"7","year":"2010","pages":"2061-2067","issue":"11","text":"49(2010), 11, Seite 2061-2067","volume":"49"},"language":["eng"],"pubHistory":["38.1999 -"],"note":["Gesehen am 31. Januar 2017"],"titleAlt":[{"title":"Rheumatology online"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"issn":["1462-0332"],"eki":["269242813"],"zdb":["1474143-X"]},"recId":"269242813","origin":[{"dateIssuedDisp":"1999-","publisherPlace":"Oxford","dateIssuedKey":"1999","publisher":"Oxford Univ. Press"}],"disp":"Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetilRheumatology"}]} 
SRT |a SCHAIERMATPROTONPUMP2920